De Lisle Partners LLP lifted its position in Kewaunee Scientific Co. (NASDAQ:KEQU – Free Report) by 36.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 42,958 shares of the technology company’s stock after buying an additional 11,511 shares during the period. De Lisle Partners LLP owned about 1.50% of Kewaunee Scientific worth $1,446,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Heron Bay Capital Management purchased a new stake in shares of Kewaunee Scientific during the 2nd quarter valued at about $252,000. Ritholtz Wealth Management lifted its position in Kewaunee Scientific by 24.6% during the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after purchasing an additional 2,156 shares during the period. Renaissance Technologies LLC boosted its holdings in Kewaunee Scientific by 13.4% in the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after purchasing an additional 10,580 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Kewaunee Scientific by 3.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after purchasing an additional 6,132 shares during the period. Institutional investors own 32.69% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Sunday.
Kewaunee Scientific Trading Up 1.4 %
Kewaunee Scientific stock opened at $42.69 on Thursday. Kewaunee Scientific Co. has a 52-week low of $16.51 and a 52-week high of $55.62. The company has a market cap of $122.52 million, a P/E ratio of 6.85 and a beta of 0.73. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48. The business has a 50-day simple moving average of $35.18 and a two-hundred day simple moving average of $41.91.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last announced its earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share (EPS) for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%. The company had revenue of $48.39 million during the quarter.
Kewaunee Scientific Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
- Five stocks we like better than Kewaunee Scientific
- Overbought Stocks Explained: Should You Trade Them?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is a buyback in stocks? A comprehensive guide for investors
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 Monster Growth Stocks to Buy Now
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.